- €890.91m
- €685.25m
Annual cashflow statement for Abivax SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | Interim Report | ARS | ARS |
| Standards: | FAS | FAS | FAS | FAS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -33.3 | -38 | -41.4 | -69.8 | -148 |
| Depreciation | |||||
| Non-Cash Items | -1.22 | -1.55 | 0.635 | 14.3 | 28.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 6.96 | 9.67 | -4.99 | -10.1 | 21.3 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -27.5 | -29.8 | -45.6 | -65.6 | -97.1 |
| Capital Expenditures | -0.941 | -0.898 | -0.047 | -3.97 | -0.265 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.571 | 0.323 | -1.53 | 0.241 | -7.83 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.37 | -0.575 | -1.57 | -3.73 | -8.1 |
| Financing Cash Flow Items | 0 | 0 | — | — | -34.6 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 24.6 | 49.9 | 78.5 | 35.6 | 335 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.23 | 19.5 | 31.4 | -33.8 | 225 |